Iterum Therapeutics

IPO

Iterum Therapeutics plc

Business Model
B2B
Last Round
Series BFeb 2021
Rounds
2

About

Iterum Therapeutics is a clinical-stage pharmaceutical company developing differentiated anti-infective drugs to combat multi-drug resistant infections.

Summary

Iterum Therapeutics is a Biotech company based in Ireland. Its most recent funding was a Series B round in Feb 2021. Investors include Arix Bioscience, Pivotal bioVenture Partners and Advent Life Sciences.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Extension RoundExtension RoundFeb 2021

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies